IL1A and cancer: Given that IL-1 promotes cancer progression [17], we compared the basal differential gene expression of LNCaP [16] and MDA-PCa-2b chronic IL-1 subline cells (Supplementary Table 1) to identify predicted tumorigenic pathways.